Results 151 to 160 of about 116,282 (198)

Studies on nicotinic acetylcholine receptors in mammalian brain. Interaction of solubilized protein with cholinergic ligands.

, 1978
Carole H. McQuarrie, Paul M. Salvaterra, H.R. Mahlers   +2 more
openalex   +1 more source

A Pharmacophore for Drugs Targeting the α4α4 Binding Site of the (α4)₃(β2)₂ Nicotinic Acetylcholine Receptor. [PDF]

J Neurochem
Kusay AS, Luo Y, O'Mara ML, Balle T.
europepmc   +1 more source

Potentiation of the M₁ muscarinic acetylcholine receptor normalizes neuronal activation patterns and improves apnea severity in Mecp2^+/- mice. [PDF]

Neurobiol Dis
Smith M, Dodis GE, Vanderplow AM, Gonzalez S, Rhee Y, Scrogin K, Gogliotti RG.   +6 more
europepmc   +1 more source

Acetylcholine receptor-β inhibition by interleukin-6 in skeletal muscles contributes to modulating neuromuscular junction during aging. [PDF]

Mol Med
Zhao Y, Yan H, Liu K, Ma J, Sun W, Lai H, Li H, Gu J, Huang H.   +8 more
europepmc   +1 more source

Influence of lipid bilayer on the structure of the muscle-type nicotinic acetylcholine receptor. [PDF]

Proc Natl Acad Sci U S A
Unwin N.
europepmc   +1 more source

Effects of Different Photoperiods on Growth Performance, Glucose Metabolism, Acetylcholine, and Its Relative Acetylcholine Receptor Modulation in Broiler Chickens. [PDF]

Animals (Basel)
Yu M, Xu M, Wang G, Feng J, Zhang M.
europepmc   +1 more source

Ravulizumab use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice. [PDF]

Front Neurol
Katyal N, Govindarajan R, Goyal N, Muley S, Muppidi S.   +4 more
europepmc   +1 more source

Key role of the TM2-TM3 loop in calcium potentiation of the α9α10 nicotinic acetylcholine receptor. [PDF]

Cell Mol Life Sci
Gallino SL, Agüero L, Boffi JC, Schottlender G, Buonfiglio P, Dalamon V, Marcovich I, Carpaneto A, Craig PO, Plazas PV, Elgoyhen AB.   +10 more
europepmc   +1 more source

Long-Term Efficacy and Safety of Ravulizumab in Adults With Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open-Label Extension. [PDF]

Eur J Neurol
Vu TH, Mantegazza R, Annane D, Katsuno M, Meisel A, Nicolle MW, Bril V, Aguzzi R, Frick G, Howard JF, CHAMPION MG Study Group.   +10 more
europepmc   +1 more source

Safety and tolerability of the M2 muscarinic acetylcholine receptor modulator BAY 2413555 in heart failure with reduced ejection fraction in the REMOTE-HF study. [PDF]

Sci Rep
Fudim M, Khan MS, Linz D, Lindenfeld J, MacRae C, Kimmeskamp-Kirschbaum N, Meyer M, Mondritzki T, Tinel H, Dinh W, Mentz RJ.   +10 more
europepmc   +1 more source